Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
- Status
- RECRUITING
- Phase
- PHASE3
Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of SRF617 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Association of Survival With Maintenance Therapy in Patients With Metastatic Breast Cancer After First-line Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion
- Status
- UNKNOWN
- Phase
- PHASE3
Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE3